NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

In short, LP has gotten the job done.

Under what possible interpretation of the events of the last 11 years could you even remotely come to this conclusion?

First of all, the job is not done. It's not even close, despite what she and her underlings have misled so many on this message board to believe. You do realize that of the steps needed to advance this trial to top line data and pursue regulatory approval, NWBO has taken none of them? That's right - none. They have not even locked the data - soft or hard - despite promising three times in the past two months that they would.

In the time I have been invested she's taken this stock from almost $9.00 per share down to $.37. She has diluted us from well under 200 million outstanding shares to more than 1.2 billion, and she managed to get the stock delisted to OTC where it dangles dangerously close to pink territory.

She has nothing but disdain for shareholders. She lies with impunity. She learned back in 2015 that this trial likely failed to meet its primary PFS endpoint - not because DCVax-L was necessarily ineffective, but more likely because they botched the way the trial was conducted - but instead of announcing this material information to shareholders, starting over from scratch with lessons learned and a still-promising treatment, she instead put the company on silent mode and began the process of seeing how long they could drag this trial out, paying themselves through an endless string of money raises and dilutions.

She has used the company as a personal piggy bank with insider deals like selling off NWBO asset Cognate to herself, pocketing millions from the sale of NWBO asset Sawston real estate, loaning the company money at a usurious interest rate, and cutting herself sweetheart warrant exceptions.

At the same time, she just can't seem to bring herself to purchase any NWBO stock on the open market, even as a PR move. She is a horrible communicator, a terrible public speaker (as demonstrated by her disastrous performance at ASCO two years ago), and regularly flouts SEC regulations and mandates as if they didn't exist.

Under what possible scenario can you say with a straight face that she has "gotten the job done"? The job is not done. Just watch what happens after they announce the "soft" lock either this week or next. Back to radio silence, and except for multiple money raises and dilutions in the interim, it may be many months before we hear anything again about the status of this trial.